Literature DB >> 22293258

Malignant lymphoma in northern Iraq: a retrospective analysis of 270 cases according to the World Health Organization classification.

R T Yaqo1, M D Hughson, F K Sulayvani, N A Al-Allawi.   

Abstract

BACKGROUND: Based on the World Health Organization (WHO) classification, the distribution of various subtypes of malignant lymphoma (ML) appears to differ by geographical region. AIMS AND
DESIGN: studying the patterns of ML retrospectively in a previously uncharted country (Iraq) and to compare it with patterns observed regionally and worldwide.
MATERIALS AND METHODS: Two hundred and seventy lymphoma patients referred to two major histopathology referral centers in Northern Iraq, were categorized according to the WHO classification, using morphology and appropriate immunohistochemistry.
RESULTS: There were 205 (76%) non-Hodgkin lymphomas (NHL) and 65 (24%) Hodgkin lymphomas (HL). Of the NHL, 91% were B-cell and 9% T-cell. The most common NHL was Diffuse large B-cell lymphoma (DLBCL) which comprised 52.2% of NHL, followed by Burkitt's lymphoma (BL) at 14.6%. The latter were mostly intestinal primaries. While follicular lymphomas (FL) were infrequent constituting 2.9 % of NHL. Extranodal primaries were found in 48.3% of NHL. Hodgkin's lymphoma (HL) included 48% nodular sclerosis (NS) and 37% mixed cellularity (MC). All HL were nodal primaries.
CONCLUSIONS: Among NHL, the high frequencies of DLBCL, extra nodal primaries and intestinal BL, and the infrequency of FL in northern Iraq, is similar to reports from nearby countries but differs considerably from the West and Far East, indicating a shared regional Middle East influence on non-Hodgkin lymphoma patterns. In contrast to earlier Iraqi and regional studies on HL, NS has surpassed MC as the most frequent histological subtype in Northern Iraq. This trend probably reflects the increasing urbanization that has taken place in this region.

Entities:  

Mesh:

Year:  2011        PMID: 22293258     DOI: 10.4103/0019-509X.92276

Source DB:  PubMed          Journal:  Indian J Cancer        ISSN: 0019-509X            Impact factor:   1.224


  8 in total

Review 1.  Peripheral T cell lymphoma in Asia.

Authors:  Sanghui Park; Young Hyeh Ko
Journal:  Int J Hematol       Date:  2014-01-31       Impact factor: 2.490

2.  Clinicopathological Spectrum of Hodgkin's and Non-Hodgkin's Lymphoma: A Tertiary Care Cancer Hospital Study in Pakistan.

Authors:  Wardah Aslam; Maryam Habib; Saeeda Aziz
Journal:  Cureus       Date:  2022-06-03

3.  Malignant lymphoma in Eastern India: A retrospective analysis of 455 cases according to World Health Organization classification.

Authors:  Santosh Kumar Mondal; Palash Kumar Mandal; Tarun Kumar Samanta; Subrata Chakaborty; Saptarshi Dutta Roy; Shravasti Roy
Journal:  Indian J Med Paediatr Oncol       Date:  2013-10

4.  Evidence of EBV infection in lymphomas diagnosed in Lusaka, Zambia.

Authors:  Doris Kafita; Trevor Kaile; Evans Malyangu; Rabecca Tembo; Ephraim Zulu; Chrispin Chisanga; Annie Kalonda; Mulemba Samutela; Pascal Polepole; Geoffrey Kwenda
Journal:  Pan Afr Med J       Date:  2018-03-28

5.  Non-Hodgkin Lymphoma in the Middle East Is Characterized by Low Incidence Rates With Advancing Age.

Authors:  Rafil T Yaqo; Sana D Jalal; Kharaman J Ghafour; Hemin A Hassan; Michael D Hughson
Journal:  J Glob Oncol       Date:  2019-04

6.  Pathology Characteristics of Lymphomas in Rwanda: A Retrospective Study.

Authors:  Fiacre Mugabe Byiringiro; Felix Manirakiza; Déogratias Ruhangaza; Thierry Zawadi Muvunyi; Belson Rugwizangoga
Journal:  East Afr Health Res J       Date:  2021-11-15

7.  Subtype distribution of lymphomas in northwestern Iran: a retrospective analysis of 659 cases according to World Health Organization classification.

Authors:  Javad Jalili; Amir Vahedi; Amin Danandehmehr; Parya Aynechi; Ali Esfahani; Yousef Roosta; Hooman Nateghian; Amirhosein Ghafouri Asbagh; Fateme Hajihoseinlou
Journal:  BMC Cancer       Date:  2022-10-12       Impact factor: 4.638

8.  Spectrum of lymphoma in Bahrain. A retrospective analysis according to the World Health Organization classification.

Authors:  Eman A Aljufairi; Sara M George; Safa A Alshaikh; Ameera A Radhi; Rawia M Mohamed
Journal:  Saudi Med J       Date:  2018-07       Impact factor: 1.484

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.